Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites seeding new resistant tumors elsewhere in the body.
An international collective of researchers is delivering new insights into why having multiple psychiatric disorders is the norm rather than the exception. In a study published today in the journal Nature, the team provides ...
Dec 10, 2025
0
118
In Brazil, researchers from the Federal University of Grande Dourados (UFGD), the State University of Campinas (UNICAMP), and São Paulo State University (UNESP) have conducted a study that confirmed the safety and anti-inflammatory, ...
Dec 10, 2025
0
67
The gut microbiome has been a rising star in the world of health science over the last several years, garnering interest from both researchers and the general public. This is mostly due to its connection to general health ...
A new study from Flinders University offers insight into how two of the world's most popular beverages, coffee and tea, may influence bone health in older women.
Dec 11, 2025
0
99
Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause heart damage in some young men and adolescents—and they've shown a possible route to reducing its ...
Dec 10, 2025
1
136
Tanning bed use is tied to almost a three-fold increase in melanoma risk, and for the first time, scientists have shown how these devices cause melanoma-linked DNA damage across nearly the entire skin surface, reports a new ...
Dec 12, 2025
0
142
Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people. While it is well known for causing muscle weakness and stiffness, DM1 also affects other organs, ...
Dec 13, 2025
0
27
A chemical found in dark chocolate could slow the rate of biological aging. Research from King's College London has found that the chemical theobromine, a common plant compound that comes from cocoa, could have anti-aging ...
Dec 10, 2025
0
200
A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet.
Dec 11, 2025
0
23
